| CTRI Number |
CTRI/2025/02/079998 [Registered on: 06/02/2025] Trial Registered Prospectively |
| Last Modified On: |
21/01/2025 |
| Post Graduate Thesis |
No |
| Type of Trial |
Interventional |
|
Type of Study
|
Physiotherapy (Not Including YOGA) |
| Study Design |
Other |
|
Public Title of Study
|
Effect of Butekyo and Papworth Breathing Exercise Techniques on Haemodynamic Parameters in Primary Hypertension Patients through Tele-Rehabilitation |
|
Scientific Title of Study
|
Effect of Butekyo and Papworth Breathing Exercise Techniques on Haemodynamic Parameters in Primary Hypertension Patients through Tele-Rehabilitation:A single-blinded Randomised controlled trial |
| Trial Acronym |
nil |
|
Secondary IDs if Any
|
| Secondary ID |
Identifier |
| NIL |
NIL |
|
|
Details of Principal Investigator or overall Trial Coordinator (multi-center study)
|
| Name |
Dr Ganesh BR |
| Designation |
Professor and Head of CVTS department |
| Affiliation |
Professor and Head of CVTS department |
| Address |
Sagar Floor Advance physiotherapy center room no.39 CVTS department room no 6 Kle Dr. Prabhakar Kore Hospital Nehru nagar Belagavi
Belgaum KARNATAKA 590010 India |
| Phone |
9844857581 |
| Fax |
|
| Email |
drganeshnssofficer@gmail.com |
|
Details of Contact Person Scientific Query
|
| Name |
Dr Ganesh BR |
| Designation |
Professor and Head of CVTS department |
| Affiliation |
Professor and Head of CVTS department |
| Address |
Sagar Floor Advance physiotherapy center room no.39 CVTS department room no 6 Kle Dr Prabhakar Kore hospital Nehru nagar Belagavi
Belgaum KARNATAKA 590010 India |
| Phone |
9844857581 |
| Fax |
|
| Email |
drganeshnssofficer@gmail.com |
|
Details of Contact Person Public Query
|
| Name |
Mugdha Vijaykumar Pendse |
| Designation |
Post- graduate Student |
| Affiliation |
KAHER Institute of Physiothrapy |
| Address |
Sagar Floor Advance physiotherapy center room no.39 Nehru nagar Belagavi
Belgaum KARNATAKA 590010 India |
| Phone |
9765391857 |
| Fax |
|
| Email |
mugdu08pendse@gmail.com |
|
|
Source of Monetary or Material Support
|
| Kle Academy of Higher Education and Research Nehru Nagar Belagavi -590010 |
|
|
Primary Sponsor
|
| Name |
KLE PREBHAKAR KORE HOSPITAL |
| Address |
Sagar Floor advance physiotherapy centre room no. 39 Kle Dr. Prabhakar Kore hospital Nehru nagar Belagavi |
| Type of Sponsor |
Private medical college |
|
|
Details of Secondary Sponsor
|
|
|
Countries of Recruitment
|
India |
|
Sites of Study
|
| No of Sites = 1 |
| Name of Principal
Investigator |
Name of Site |
Site Address |
Phone/Fax/Email |
| DR Ganesh BR |
DR. PRABHAKAR KORE HOSPITAL |
Sagarfloor advanced physiotherapy center room no. 39 Dr. Prabhakar Kore Hospital and MRC Belgaum karnataka Belgaum KARNATAKA |
9844857581
drganeshnssofficer@gmail.com |
|
|
Details of Ethics Committee
|
| No of Ethics Committees= 1 |
| Name of Committee |
Approval Status |
| KAHER Istitute of Physiotherapy |
Approved |
|
|
Regulatory Clearance Status from DCGI
|
|
|
Health Condition / Problems Studied
|
| Health Type |
Condition |
| Patients |
(1) ICD-10 Condition: I10||Essential (primary) hypertension, |
|
|
Intervention / Comparator Agent
|
| Type |
Name |
Details |
| Intervention |
Breathing Exercises
1. Buteyko brething technique
2. Papworth breathing technique
|
Baseline assesssment will taken and after which for 2 weeks each day through video call sessions excercises will be taught. |
| Comparator Agent |
Diaphragmatic breathing technique |
Baseline assesssment will taken and after which for 2 weeks each day through video call sessions excercises will be taught. |
|
|
Inclusion Criteria
|
| Age From |
35.00 Year(s) |
| Age To |
55.00 Year(s) |
| Gender |
Both |
| Details |
All genders clinically diagnosed with clinically with primary hypertension
Age group : 35 – 55 yrs
Patient engaged in some kind of physical activity at least 3 times a week
Patient who have taking medications for hypertension
Patient willing to participate
Smartphone users
|
|
| ExclusionCriteria |
| Details |
with active respiratory infection or kidney problem
with a history of organ transplant
undergoing any cardiac or respiratory rehabilitation program
with history of rib fracture
unwilling to participate
|
|
|
Method of Generating Random Sequence
|
Other |
|
Method of Concealment
|
Other |
|
Blinding/Masking
|
Participant Blinded |
|
Primary Outcome
|
| Outcome |
TimePoints |
Blood Pressure
Pulse Rate
Oxygen Saturation
|
Blood Pressure
Pulse Rate
Oxygen Saturation
Day 0 and at 7th day and at last day that is 14th day
|
|
|
Secondary Outcome
|
| Outcome |
TimePoints |
| Oxygen saturation |
Day 0 and day 7 and day 14 |
|
|
Target Sample Size
|
Total Sample Size="36" Sample Size from India="36"
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" |
|
Phase of Trial
|
Phase 1/ Phase 2 |
|
Date of First Enrollment (India)
|
07/02/2025 |
| Date of Study Completion (India) |
Applicable only for Completed/Terminated trials |
| Date of First Enrollment (Global) |
07/02/2025 |
| Date of Study Completion (Global) |
Applicable only for Completed/Terminated trials |
|
Estimated Duration of Trial
|
Years="0" Months="6" Days="0" |
|
Recruitment Status of Trial (Global)
|
Not Yet Recruiting |
| Recruitment Status of Trial (India) |
Not Yet Recruiting |
|
Publication Details
|
N/A |
|
Individual Participant Data (IPD) Sharing Statement
|
Will individual participant data (IPD) be shared publicly (including data dictionaries)?
Response - NO
|
|
Brief Summary
|
The study will obtain ethical clearance from the Institutional Ethical Committee and register with CTRI before initiation. Participants will be selected based on inclusion and exclusion criteria. The purpose and procedures of the study will be explained, and informed consent will be collected. Participants will be randomly allocated into three groups. Baseline measurements will be taken at a tertiary care hospital during the first session. Daily video call sessions will be conducted to monitor participants. Follow-up visits will occur on the 7th day and the final session to reassess outcome measures. |